New Delhi, December 28
Expanding India’s vaccine basket, the Central Drug Authority has approved the Serum Institute of India’s Covid-19 vaccine Covovax, Biological E’s jab Corbevax
Six COVID-19 vaccines - Serum Institute's Covishield, Bharat Biotech's Covaxin, Zydus Cadila's ZyCoV-D, Russia's Sputnik V and the US-made Moderna and Johnson and Johnson - had already received EUA from the Indian drug regulator earlier.
India on Tuesday granted approval to anti-Covid pill Molnupiravir, Serum Institute of India's Covid-19 vaccine Covovax and Biological E's vaccine Corbevax after an expert panel of the country's central drug authority recommended granting emergency use authorisation.
Govt panel recommends EUA for Covovax, Corbevax and anti-Covid pill molnupiravir dtnext.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dtnext.in Daily Mail and Mail on Sunday newspapers.